University of Illinois Cancer Center member Abiola Ibraheem, MD, who is from Nigeria, was elected Vice President: North America for the African Organisation for Research and Training in Cancer (AORTIC), whose members throughout Africa and in the international cancer community are dedicated to reducing the cancer burden in Africa.
The 2024-2025 AORTIC Council Members were elected November 4 during the AORTIC 2023 conference held in Dakar, Senegal.
A UI Health medical oncologist focused on cancer disparities, Ibraheem graduated from medical school in Nigeria and practiced in Lagos State before heading to the Morehouse School of Medicine in Atlanta for an internship and residency followed by a fellowship at the University of Chicago.
A principal investigator on global breast cancer clinical trials, Ibraheem also serves as liaison between the American Society of Clinical Oncology (ASCO) and the newly established Sub-Saharan African Council. She chairs the diversity committee at pharmaceutical giant Eli Lilly, where she focuses on representation of minorities in breast cancer trials, according to her candidate bio. She is also part of the Center for Global Health at the University of Illinois College of Medicine in Chicago.
“Dr. Abiola Ibraheem is an outstanding choice to serve as the North American Vice President for the African Organisation on Research and Training in Cancer (AORTIC). Dr. Ibraheem is a much-valued member of the ASCO International Affairs Committee and serves as the committee’s liaison to the ASCO Sub-Saharan regional council, which held a vibrant and productive first in-person meeting this past week in Senegal during the AORTIC meeting,” said Julie Gralow, MD, FACP, FASCO, Chief Medical Officer (CMO) and Executive Vice President of ASCO.